Travv
Latest round
- Seed
Last raised
- May 2026
Total raised
- $1.6M
Investors
- 2
About Travv
Based in the US, Travv, Inc. specializes in artificial intelligence-driven veterinary diagnostics, enhancing traditional procedures to improve the accuracy and efficiency of animal healthcare services. Cofounded in 2025 in Stillwater, US, by Derick Whitley CEO , Tony Pease, Zachary Runyan. Travv, Inc. delivers advanced veterinary diagnostics using AI technology. In May 2026, Travv, Inc.vc. The sole deal to date reflects the company’s growing focus on innovation in veterinary services. Travv specializes in advanced veterinary diagnostics through a modern, integrated platform that harnesses artificial intelligence (AI) to enhance traditional procedures such as radiology and pathology. The company's core offerings include a suite of cloud-based diagnostic tests designed to streamline workflows for veterinarians and provide them with expert diagnostic support. By leveraging high-fidelity datasets curated by domain experts, Travv aims to improve diagnostic accuracy and efficacy in veterinary healthcare. The products are targeted towards global veterinarians and diagnostic professionals, facilitating enhanced patient care across various regions, including North America, Europe, and parts of Asia.Travv, Inc. generates revenue through a subscription-based model, wherein veterinary practices and diagnostic facilities can access its suite of cloud-based diagnostic services. Clients typically engage in annual or monthly subscription plans that offer tiered access to various AI-powered diagnostic tools and resources. This business model is structured to support both individual practitioners and larger veterinary organizations, fostering a B2B relationship with its clientele. Specific pricing plans are developed around the breadth of services utilized, allowing customers to tailor their subscriptions according to their diagnostic needs. intends to further develop and expand its artificial intelligence veterinary diagnostics platform. Travv plans to launch new products tailored to the needs of veterinarians by the end of 2026 and aims to broaden its reach into new geographic markets, specifically targeting Asia and Europe within the next 18 months.
Who invested in Travv
2 investors across 1 round
See all investors in Travv
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 6, 2026
Amount
$1.6M
Investors
Questions about Travv
Who invested in Travv?
Travv has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Travv raised?
Travv has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Travv last raise money?
Travv's most recent round on record is a Seed, in May 2026.
What does Travv do?
Travv is a healthcare it company.
Where is Travv headquartered?
Travv is headquartered in Stillwater, US.
Which VCs invest in companies like Travv?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Travv's stage. Their profiles are linked below.
VCs backing healthcare it startups at Seed
Raising like Travv? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.